Basic Information
| LncRNA/CircRNA Name | LINC00152 |
| Synonyms | CYTOR, C2orf59, LINC00152, NCRNA00152 |
| Region | GRCh38_2:87454781-87636740 |
| Ensemble | ENSG00000222041 |
| Refseq | NR_024204 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR, Microarray etc. |
| Sample | lung cancer tissues, cell lines |
| Expression Pattern | up-regulated |
| Function Description | Our study indicates LINC00152 plays an important role in lung tumor growth and is potentially a diagnostic/prognostic marker. LINC00152 overexpression caused by histone acetylation. |
| Pubmed ID | 28592840 |
| Year | 2017 |
| Title | Overexpression of LINC00152 correlates with poor patient survival and knockdown impairs cell proliferation in lung cancer |
External Links
| Links for LINC00152 | GenBank HGNC NONCODE |
| Links for lung cancer | OMIM COSMIC |